5-HT₂ and 5-HT₇ receptor agonists facilitate plantar stepping in chronic spinal rats through actions on different populations of spinal neurons

Front Neural Circuits. 2014 Aug 19:8:95. doi: 10.3389/fncir.2014.00095. eCollection 2014.

Abstract

There is considerable evidence from research in neonatal and adult rat and mouse preparations to warrant the conclusion that activation of 5-HT2 and 5-HT1A/7 receptors leads to activation of the spinal cord circuitry for locomotion. These receptors are involved in control of locomotor movements, but it is not clear how they are implicated in the responses to 5-HT agonists observed after spinal cord injury. Here we used agonists that are efficient in promoting locomotor recovery in paraplegic rats, 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OHDPAT) (acting on 5-HT1A/7 receptors) and quipazine (acting on 5-HT2 receptors), to examine this issue. Analysis of intra- and interlimb coordination confirmed that the locomotor performance was significantly improved by either drug, but the data revealed marked differences in their mode of action. Interlimb coordination was significantly better after 8-OHDPAT application, and the activity of the extensor soleus muscle was significantly longer during the stance phase of locomotor movements enhanced by quipazine. Our results show that activation of both receptors facilitates locomotion, but their effects are likely exerted on different populations of spinal neurons. Activation of 5-HT2 receptors facilitates the output stage of the locomotor system, in part by directly activating motoneurons, and also through activation of interneurons of the locomotor central pattern generator (CPG). Activation of 5-HT7/1A receptors facilitates the activity of the locomotor CPG, without direct actions on the output components of the locomotor system, including motoneurons. Although our findings show that the combined use of these two drugs results in production of well-coordinated weight supported locomotion with a reduced need for exteroceptive stimulation, they also indicate that there might be some limitations to the utility of combined treatment. Sensory feedback and some intraspinal circuitry recruited by the drugs can conflict with the locomotor activation.

Keywords: locomotion; recovery; serotonin; spinal cord; total transection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 8-Hydroxy-2-(di-n-propylamino)tetralin / therapeutic use*
  • Analysis of Variance
  • Animals
  • Electromyography
  • Female
  • Hindlimb / physiopathology
  • Locomotion / drug effects
  • Movement Disorders / drug therapy*
  • Movement Disorders / etiology
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / physiopathology
  • Neurons / drug effects*
  • Quipazine / therapeutic use*
  • Rats
  • Rats, Wistar
  • Serotonin Receptor Agonists / therapeutic use*
  • Spinal Cord Injuries / complications
  • Spinal Cord Injuries / pathology
  • Video Recording

Substances

  • Serotonin Receptor Agonists
  • Quipazine
  • 8-Hydroxy-2-(di-n-propylamino)tetralin